Advances in Pathogenesis and Pathology Diagnosis of Gynecologic Cancers
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 30 September 2026 | Viewed by 2
Special Issue Editor
2. Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Interests: diagnostic challenges in gynecologic pathology; endometrial serous carcinogenesis; endometrial cancer pathogenesis; TCGA-endometrial cancer molecular classification; targeted therapy; immune therapy; uterine sarcoma; clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in molecular pathology and precision medicine have profoundly reshaped our understanding of gynecologic cancers. This Special Issue aims to highlight novel discoveries in the pathogenesis, classification, and diagnostic approaches of ovarian, endometrial, cervical, and related gynecologic malignancies. We welcome original research, comprehensive reviews, and translational studies that explore molecular mechanisms, diagnostic biomarkers, histopathologic correlations, and emerging technologies in tissue-based and liquid biopsy diagnostics. By integrating molecular and morphologic insights, this collection seeks to bridge the gap between laboratory research and clinical practice, ultimately improving patient management and outcomes in gynecologic oncology.
Prof. Dr. Wenxin Zheng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic cancers
- molecular pathology
- tumor pathogenesis
- diagnostic biomarkers
- precision medicine
- endometrial carcinoma
- ovarian cancer
- cervical cancer
- histopathology
- translational research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
